Physician
Hematology
Dr. Robert A. Nagourney, MD
|
|
Give Review
Robert Nagourney is an expert in the field of Hematology. She has 1 awards "Top MD". Robert A. Nagourney, MD is also published. She has 26 publications published. The lastest publication: "2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.' She is registered with Medicare.
Publications
- Medicinal food meets epigenetics.
- Carboplatin plus gemcitabine repeating doublet therapy in recurrent breast cancer.
- Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group.
- Ex vivo programmed cell death and the prediction of response to chemotherapy.
- Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
- Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients.
- TCL-1, MTCP-1 and TML-1 gene expression profile in non-leukemic clonal proliferations associated with ataxia-telangiectasia.
- PC-SPES.
- Multifocal Breast Cancer in Young Women with Prolonged Contact between Their Breasts and Their Cellular Phones.
- Herbal composition PC-SPES for management of prostate cancer: identification of active principles.
- An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway.
- Chemosensitivity and resistance assays: a systematic review?
- Gemcitabine plus cisplatin in breast cancer.
- Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients.
- Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer.
- 2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.
- Perturbation of in vitro drug resistance in human lymphatic neoplasms by combinations of putative inhibitors of protein kinase C.
- Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapy.
- Carcinoid carcinomatous meningitis.
- Radiation response of cells from human tumor biopsies as assessed by a dye exclusion technique: a possible predictive assay.
- Multidrug resistance in acute myeloid leukemia.
- Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues.
- A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitros...
- A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice.
- Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics.
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- Top MD
Education
-
Scripps Clinic -
Georgetown University Hospital -
McGill University Faculty of Medicine
Hospital
-
Hoag Memorial Hospital Presbyterian -
Long Beach Memorial Medical Center
Drug Facts
| NPI NUMBER | 1285694018 | |
| NPPES Provider LastName | NAGOURNEY | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 908062759 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 309.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 5.5 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285694018 |
| Last Name Of The Provider | NAGOURNEY |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
Dr. Mark M. Ngo, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Padmini R. Iyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond H. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald R. Hanson, MD |
|
Dr. Lihong Wu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walter Schreiber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Ling Lo, PA-C |